Katherine Achtien

Title: Katherine Achtien: Innovator in Glycosylation Patterns

Introduction

Katherine Achtien is a prominent inventor based in St. Louis, MO (US). She has made significant contributions to the field of biotechnology, particularly in the area of glycosylation patterns in recombinant proteins. With a total of 2 patents, her work is paving the way for advancements in medical and pharmaceutical applications.

Latest Patents

Katherine's latest patents include a method of producing human-like glycosylation patterns using cells deficient in glutamine synthase, CMP-N-acetylneuraminic acid hydroxylase, and/or glycoprotein alpha-1,3-galactosyltransferase. This invention provides non-human mammalian cell lines that are deficient in CMP-Neu5Ac hydroxylase (Cmah) and/or glycoprotein alpha-1,3-galactosyltransferase (Ggta1). Additionally, she has developed methods for using these cells to produce recombinant proteins with human-like patterns of glycosylation.

Career Highlights

Katherine is currently employed at Sigma-Aldrich Co. LLC, where she continues to innovate and contribute to the field. Her work has garnered attention for its potential applications in creating more effective therapeutic proteins.

Collaborations

Katherine collaborates with notable colleagues, including Nan Lin and Henry George, who share her passion for advancing biotechnological research.

Conclusion

Katherine Achtien's innovative work in glycosylation patterns is making a significant impact in biotechnology. Her patents and collaborations highlight her dedication to improving recombinant protein production, which could lead to breakthroughs in medical treatments.